Evidence map›Paper›PMID 35328432›Full record

ArticleInternational journal of molecular sciences2022

Optimized Protocol for Proportionate CNS Cell Retrieval as a Versatile Platform for Cellular and Molecular Phenomapping in Aging and Neurodegeneration.

Quratul Ain, Christian W Schmeer, Diane Wengerodt, Yvonne Hofmann, Otto W Witte, Alexandra Kretz

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cellular Senescence in Physiological and Pathological Processes.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Quratul AinHans Berger Department of Neurology, Jena University Hospital, 07747 Jena, Germany.
Christian W SchmeerHans Berger Department of Neurology, Jena University Hospital, 07747 Jena, Germany.ORCID 0000-0002-2289-0126
Diane WengerodtHans Berger Department of Neurology, Jena University Hospital, 07747 Jena, Germany.
Yvonne HofmannDepartment of Internal Medicine V, Jena University Hospital, 07747 Jena, Germany.
Otto W WitteHans Berger Department of Neurology, Jena University Hospital, 07747 Jena, Germany.ORCID 0000-0003-2101-4105
Alexandra KretzHans Berger Department of Neurology, Jena University Hospital, 07747 Jena, Germany.

Funding

Else-Kröner Research College 'Anti Age' [to O.W.W.]Graduate Academy (GA) of the Jena University PhD stipend to Q.A.Interdisciplinary Centre for Clinical Research (IZKF) Jena [FF01 to A.K.]Ministry for Economics, Sciences and Digital Society of Thuringia (TMWWDG), in frame of the ProExcellence Initiative RegenerAging RegenerAging-52-5581-413-FSU-I-03/14 to A.K
6 · The paper itself

Abstract

Efficient purification of viable neural cells from the mature CNS has been historically challenging due to the heterogeneity of the inherent cell populations. Moreover, changes in cellular interconnections, membrane lipid and cholesterol compositions, compartment-specific biophysical properties, and intercellular space constituents demand technical adjustments for cell isolation at different stages of maturation and aging. Though such obstacles are addressed and partially overcome for embryonic premature and mature CNS tissues, procedural adaptations to an aged, progeroid, and degenerative CNS environment are underrepresented. Here, we describe a practical workflow for the acquisition and phenomapping of CNS neural cells at states of health, physiological and precocious aging, and genetically provoked neurodegeneration. Following recent, unprecedented evidence of post-mitotic cellular senescence (PoMiCS), the protocol appears suitable for such de novo characterization and phenotypic opposition to classical senescence. Technically, the protocol is rapid, efficient as for cellular yield and well preserves physiological cell proportions. It is suitable for a variety of downstream applications aiming at cell type-specific interrogations, including cell culture systems, Flow-FISH, flow cytometry/FACS, senescence studies, and retrieval of omic-scale DNA, RNA, and protein profiles. We expect suitability for transfer to other CNS targets and to a broad spectrum of engineered systems addressing aging, neurodegeneration, progeria, and senescence.

Indexed as

ProgeriaAgedAgingCell SeparationCellular SenescenceHumansamyotrophic lateral sclerosis (ALS)CNS agingCNS cell isolationneurodegenerationneuropathologyprogeriasenescence

Identifiers

PMID35328432
PMCPMC8950438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.